Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.6B |
| 2 |
Broadcom
AVGO
|
+$1.11B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$882M |
| 4 |
JPMorgan Chase
JPM
|
+$628M |
| 5 |
Tesla
TSLA
|
+$594M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.54B |
| 2 |
Visa
V
|
+$1.39B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.13B |
| 4 |
Amazon
AMZN
|
+$771M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$575M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 45.6% |
| 2 | Technology | 19.83% |
| 3 | Financials | 7.37% |
| 4 | Consumer Discretionary | 6.6% |
| 5 | Communication Services | 5.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
CNSY
4976
Cerenome
CNSY
$12.1M
| $36 | ﹤0.01% |
4
-38
| -90% | -$497 |
2025 Q1
1 quarter
|
|
4977
Bolt Biotherapeutics
BOLT
$6.65M
| $35 | ﹤0.01% |
6
-1
| -14% | -$7 |
2022 Q1
13 quarters
|
|
4978
Socket Mobile
SCKT
$5.86M
| $35 | ﹤0.01% |
30
| – | – |
2016 Q2
36 quarters
|
|
4979
Innovator US Equity Ultra Buffer ETF May
UMAY
$140M
| $35 | ﹤0.01% |
1
-5,163
| -100% | -$174K |
2024 Q3
3 quarters
|
|
4980
ClearSign Technologies
CLIR
$23.9M
| $30 | ﹤0.01% |
+5
| New | +$30 |
2025 Q1
1 quarter
|
|
|
CYPH
4981
Cypherpunk Technologies Inc
CYPH
$327M
| $30 | ﹤0.01% |
100
-28,724
| -100% | -$10.5K |
2025 Q1
1 quarter
|
|
4982
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
$10.9B
| $30 | ﹤0.01% |
1
| – | – |
2024 Q3
3 quarters
|
|
4983
Ternium
TX
$11.1B
| $30 | ﹤0.01% |
1
-5,849
| -100% | -$168K |
2017 Q2
32 quarters
|
|
|
IMMP
4984
Immutep
IMMP
$32.1M
| $26 | ﹤0.01% |
1
| – | – |
2024 Q4
2 quarters
|
|
4985
State Street SPDR Portfolio Aggregate Bond ETF
SPAB
$9.78B
| $26 | ﹤0.01% |
1
| – | – |
2024 Q4
2 quarters
|
|
4986
Twin Disc
TWIN
$414M
| $26 | ﹤0.01% |
3
-11,298
| -100% | -$83.5K |
2023 Q3
7 quarters
|
|
|
ZSQR
4987
Z Squared Inc
ZSQR
$210M
| $23 | ﹤0.01% |
3
| – | – |
2022 Q4
10 quarters
|
|
4988
Ovid Therapeutics
OVID
$465M
| $23 | ﹤0.01% |
71
-63,847
| -100% | -$19.2K |
2023 Q2
8 quarters
|
|
4989
State Street SPDR Portfolio Long Term Corporate Bond ETF
SPLB
$1.15B
| $23 | ﹤0.01% |
1
| – | – |
2024 Q4
2 quarters
|
|
|
NBTX
4990
Nanobiotix
NBTX
$1.31B
| $19 | ﹤0.01% |
4
| – | – |
2024 Q2
4 quarters
|
|
4991
Ultralife
ULBI
$108M
| $18 | ﹤0.01% |
2
-10,209
| -100% | -$60.5K |
2023 Q3
7 quarters
|
|
4992
Lightwave Logic
LWLG
$879M
| $17 | ﹤0.01% |
14
-160,522
| -100% | -$169K |
2022 Q2
12 quarters
|
|
|
BTAI
4993
DELISTED
BioXcel Therapeutics
BTAI
| $14 | ﹤0.01% |
8
-1,902
| -100% | -$3.15K |
2021 Q2
16 quarters
|
|
4994
Geospace Technologies
GEOS
$62.1M
| $14 | ﹤0.01% |
1
-12,279
| -100% | -$91.6K |
2023 Q3
7 quarters
|
|
|
LGHL
4995
Lion Group Holding
LGHL
$185K
| – | – |
0
| – | – |
2022 Q1
13 quarters
|
|
4996
VirTra
VTSI
$31.6M
| $14 | ﹤0.01% |
2
-14,146
| -100% | -$74.5K |
2024 Q2
4 quarters
|
|
|
BPT
4997
DELISTED
BP Prudhoe Bay Royalty Trust
BPT
| $12 | ﹤0.01% |
23
| – | – |
2020 Q2
20 quarters
|
|
4998
Lisata Therapeutics
LSTA
$15.9M
| $12 | ﹤0.01% |
4
| – | – |
2015 Q4
38 quarters
|
|
4999
FuelCell Energy
FCEL
$1.48B
| $11 | ﹤0.01% |
2
-22,196
| -100% | -$108K |
2019 Q4
22 quarters
|
|
5000
a.k.a. Brands
AKA
$119M
| $10 | ﹤0.01% |
1
-653
| -100% | -$7.22K |
2024 Q2
4 quarters
|
|
Similar funds
Barclays's Q2 2025 Portfolio in Review
As of Q2 2025, Barclays held 5,681 positions worth $436B, up 24% from $353B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Barclays's Q2 2025 filing shows 461 new, 2,914 increased, 1,345 reduced and 463 closed positions. Its largest new stake was iShares MBS ETF: 4,310,047 shares worth $405M. The largest sale was Honeywell, an estimated $1.54B.
By sector, the portfolio is most concentrated in Miscellaneous at 46% of assets, up from 41% a quarter earlier, followed by Technology and Financials.
- Barclays's largest Q2 2025 buy was iShares MBS ETF: 4,310,047 shares worth $405M.
- Barclays added most to NVIDIA in Q2 2025, an estimated $1.6B increase.
- Barclays's biggest Q2 2025 reduction was Honeywell, cutting an estimated $1.54B.
- Barclays fully exited Berry Global Group, Inc. in Q2 2025, selling an estimated $173M.
- Barclays's ten largest holdings make up 43% of its $436B portfolio in Q2 2025.
- Barclays opened 461 new positions and closed 463 in Q2 2025.
- Barclays's portfolio value rose 24% quarter-over-quarter to $436B.
Based on Barclays's 13F filing for Q2 2025, filed 13 Aug 2025.